Related Articles
Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease
Impact of cholesterol metabolism and the LXRα-SREBP-1c pathway on nonalcoholic fatty liver disease
Metformin attenuates palmitic acid-induced insulin resistance in L6 cells through the AMP-activated protein kinase/sterol regulatory element-binding protein-1c pathway
The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease
Silibinin protects β cells from glucotoxicity through regulation of the Insig-1/SREBP-1c pathway